InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the complete record of transactions filed by Patel Sushil, Director. Officer active across 2 companies, notably Replimune Group, Inc.. In total, 5 reports have been published. Total volume traded: €149k. The latest transaction was disclosed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
010,500 shares0
Common Stock
SEC:0001567619-22-013113:0·
€149,36710,687 shares@ €13.97650.035% mcap100.0% of flow
Common Stock
SEC:0001104659-22-062607:0·
052,500 shares0
Common Stock
SEC:0001104659-22-042768:0·
088,333 shares0
Common Stock
SEC:0001104659-21-061913·
088,333 shares0
Common Stock
SEC:0001104659-21-061913:0·
5 of 5 declarations
About Patel Sushil
Patel Sushil is the Chief Commercial Officer and Board Member of Replimune Group, Inc. and Revolution Medicines, Inc. In these roles, he is responsible for commercial strategy and business development, contributing to the growth of the companies in the biopharmaceutical sector.
